F757 in Wisconsin. Pick another state for the same tag.
Against expectation — 2025
Wisconsin cites F757 more often than its own record predicts
Versus expected share1.28×
1.28 times the share F757 takes of citations nationally.
Share of Wisconsin citations1.02%
Of every deficiency written in Wisconsin in 2025, this is the portion that was F757.
Wisconsin1.02%
National0.80%
Share of all citations that were F757.
Each state is measured against its own expected share, not against other states.
In the surveyor’s words
What Wisconsin surveyors wrote
F757 findings written in Wisconsin, one from each severity band recorded here, most serious first.
Severity is as the surveyor wrote it. Some findings had already been corrected before the survey.
J · Immediate jeopardy, isolatedJune 28, 2024
Based on record reviews, interviews, and facility policy review, the facility failed to ensure that 1 of 3 sampled residents reviewed for Coumadin usage (R2) received ongoing laboratory testing to monitor the therapeutic dose the resident received.
R2 was admitted to the facility with an order for Coumadin (an anticoagulation medication). Use of this medication requires frequent laboratory testing to ensure a person is receiving the correct dose to remain in therapeutic range. The last test that was completed was on [DATE]. R2 began to develop multiple bruises, which can be a sign of over anticoagulation (too much Coumadin). Neither nursing nor pharmacy identified there were no orders for labs and that R2 was not being monitored. …
Based on interview and record review, the facility failed to ensure that each resident's drug regimen was free from unnecessary drugs for 1 or 7 residents (R2). R2 has a history of an elevated international normalized ratio (INR) blood test for blood clotting time while taking an anticoagulant (blood thinner) medication. R2 did not receive adequate monitoring while receiving the anticoagulant medication in conjunction with an antibiotic. Registered Nurse (RN) C assessed R2 and found a large amount of blood in R2's stool, on an incontinent pad, and when R2 was rolled a large amount of blood expelled from R2's rectum. R2 was transferred to the emergency room and found to have a critical INR level of 9.3. …
D · No harm, potential for more than minimal, isolatedAugust 5, 2026
Based on interview and record review, the facility did not monitor for adverse reactions to a high-risk medication for 1 resident (R) (R33) of 3 sampled residents. R33 was prescribed Novolog and Lantus insulin. The facility did not monitor R33 for adverse reactions to the medications. In addition, R33 did not have hypoglycemia management orders.Findings include:The facilitiy's Accucheck/Blood Glucose Monitoring policy, revised 2/7/26, indicates: It is the policy of this facility to perform accuchecks as ordered by the resident's physician and to report alert levels to the attending physician as warranted. Standard parameters are as follows: Blood glucose level of <60 or >400 unless otherwise specified by the physician .3. …
Deficiency Index is independent and is not affiliated with, endorsed by, or approved by CMS, Medicare, or any government agency. About this data · Report a correction